Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Cost heh. Came full circle on that one....
I can’t imagine how cost or time would be a factor in a trial of that size, but perhaps.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158669003
Sounds like we’re on the same page.
I think if the company was planning to conduct trials in the US they would have said so, but honestly I have no idea what the company is thinking at this point. That’s why I asked the question....
LOL. Thanks.
US companies file IND’s with the FDA for foreign trials. The company made no mention of a US based trial, but it’s a good guess nonetheless.
I know what it says. What it doesn’t say is that they’re planning trials in the US. I’m not saying they aren’t, but to say they are from the PR is a guess in my opinion. I’m not asking for you or anyone else here to agree with me.
Lmao. I said nothing of the sort.
The company would file an IND with the FDA for overseas trials. Perhaps therein lies the “confusion”.
Exactly. No mention that trials will be held in the US. That part of your statement is a guess.
The PR didn’t say squat about a clinical trial being held in the US. That part of your statement is a guess.
That’s one hell of a guess.
Any guesses how/why IPIX ended up overseas with their CV-19 clinical trial?
#filltheipixGAP! 15 pennies.!
$IPIX
Northern Dynasty: Compensatory Mitigation Plan for Alaska's Pebble Project submitted to US Army Corps of Engineers!
They have $6M in the bank for the trial and don’t need to dilute
Doesn’t exist imo. I’ve looked.
If you’ll give me a copy of the signed lease, I’ll answer that question for you.
From 10K - “On January 22, 2020, the Company filed a complaint against Cummings Properties, LLC in the Superior Court of the Commonwealth of Massachusetts (C.A. No. 20-77CV00101), seeking, among other things, declaratory relief that the lease for the Company’s prior principal executive offices did not automatically extend for an additional five years from September 2018, return of the Company’s security deposit, and damages. This action is in the preliminary stages and the Company is currently unable to determine the probability of the outcome or reasonably estimate the loss or gain, if any.”
LoL. Makes me wonder.
Ya. That makes sense given today’s low.
Gap still open!
#filltheipixGAP! 15 pennies.!
$IPIX
Trade of the day happening now!
Right! This is far from over!
Your argument can be made for NV and WI too!
NAK is looking good as it sits. Fingers crossed!
Clear it up for us. When were they received?
I saw the company made an announcement today. Your response didn’t answer my question which was, if it clears it up, when were they received?
As did I.
lol. Ok.
There’s a shit ton of shares for sale between the SP and 36 pennies.
Say what?
Clears it up? As you’ve pointed out, they’ve reported receiving written responses twice now. If it clears it up, when were they received?
So those figures don’t reflect the past year as your initial post eluded to. Now you’re telling us you’re grabbing the info from here?
https://money.tmx.com/en/quote/NDM/company
I gave you the correct link from SEDI once. Here it is again.
https://ceo.ca/api/sedi/?symbol=ndm&amount=&transaction=&insider=
Sure they have.
“the FDA has reviewed study protocols within 24 hours in many cases and has reviewed single-patient expanded access requests generally within three hours.”
"Confirmation of the meeting being granted by FDA, with return of written responses, has been received."
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-continues-accelerate-development-novel-therapies-covid-19?utm_campaign=Coronavirus%20Treatment%20Acceleration%20Program%20%28CTAP%29&utm_medium=email&utm_source=Eloqua
http://www.ipharminc.com/press-release/2020/10/2/innovation-pharmaceuticals-announces-pre-ind-meeting-request-granted-by-fda-for-the-study-of-brilacidin-for-the-treatment-of-covid-19
Yes. There was. I read the email and then saw it was removed from the content of the post. The post was addressed to you.
The c&p was removed from the content of the post. Disinformation at its finest.
So did I.
Which FDA goals for an IND application couldn’t possibly have been met at this point?
Which FDA goals for an IND application couldn’t possibly have been met at this point?